---
figid: PMC8176998__BCP-86-1690-g002
figtitle: Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8176998
filename: BCP-86-1690-g002.jpg
figlink: /pmc/articles/PMC8176998/figure/bcp14316-fig-0002/
number: F2
caption: Hypoxia‐adenosine pathway in the tumour microenvironment. Tissue hypoxia
  increases adenosine production through CD39 and CD73, and decreases adenosine removal
  by inhibition of adenosine kinase. Extracellular adenosine via A2A and A2B receptors
  exerts an immunosuppressive effect on T cells, APCs and NK cells
papertitle: Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies.
reftext: Yara Abdou, et al. Br J Clin Pharmacol. 2020 Sep;86(9):1690-1702.
year: '2020'
doi: 10.1111/bcp.14316
journal_title: British Journal of Clinical Pharmacology
journal_nlm_ta: Br J Clin Pharmacol
publisher_name: John Wiley and Sons Inc.
keywords: checkpoint inhibitor | CTLA‐4 | immune checkpoints | immunotherapy | PD‐1
  | PD‐L1 | resistance
automl_pathway: 0.9582626
figid_alias: PMC8176998__F2
figtype: Figure
redirect_from: /figures/PMC8176998__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8176998__BCP-86-1690-g002.html
  '@type': Dataset
  description: Hypoxia‐adenosine pathway in the tumour microenvironment. Tissue hypoxia
    increases adenosine production through CD39 and CD73, and decreases adenosine
    removal by inhibition of adenosine kinase. Extracellular adenosine via A2A and
    A2B receptors exerts an immunosuppressive effect on T cells, APCs and NK cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - adp
  - Amph
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - ATP8A2
  - WDTC1
  - ENTPD1
  - APRT
  - MFAP1
  - NT5E
  - APC
  - PROC
  - ADORA2A
---
